Omega Medical Imaging

Omega Medical Imaging is a pioneering medical device company focused on revolutionizing interventional imaging through AI-enabled radiation reduction. Its flagship technology, the FluoroShield™ system, acts as a secondary collimator, using AI to define a Region of Interest (ROI) and has demonstrated reductions in radiation exposure of up to 84%. The company targets the cardiology and gastroenterology markets with its FDA-approved Soteria.AI system for cardiology and its E-View.AI system for endoscopy, positioning itself at the intersection of medical imaging, AI, and patient/staff safety. As a private, US-based manufacturer, it emphasizes domestic production and integration into existing clinical workflows.

FluoroShield™ AI platform: An integrated hardware and AI software system that acts as a dynamic secondary collimator. It uses real-time AI to automatically detect the physician's Region of Interest (ROI) during interventional procedures and shapes the X-ray beam to reduce radiation exposure to peripheral anatomy by up to 84%, while maintaining image quality in the ROI.

Omega competes in the high-end interventional imaging market dominated by multinational conglomerates like Siemens Healthineers, GE Healthcare, and Philips. These competitors have comprehensive product portfolios, global scale, and are also developing AI-driven dose management tools. Omega's differentiation lies in its focused, FDA-approved AI platform (FluoroShield™) and its US-based manufacturing.